Pharmacy Billing Specialists
Pharmacy Billing - Every Fill Reimbursed, Your Margin Protected
High-cost specialty drugs, compounds, and clawed-back fees steadily erode your margin. We make sure every claim is submitted, defended, and reimbursed so your pharmacy keeps the money it earned - from ingredient costs to specialty approvals.
Frequent Revenue Leaks in Pharmacy Billing
Pharmacy and compounding businesses face unique billing complexities that can significantly impact revenue and profitability.
One Missed Detail on a Compound and the Entire Claim Comes Back Unpaid
A compounded medication is only reimbursed when every ingredient and quantity is captured correctly. Miss one and the whole claim is denied - leaving your pharmacy holding the cost of a prescription you already made and handed to the patient.
Impact: A single missed detail on a compound leaves you holding the full cost of the prescription
Get the Costs and Fees Wrong and Your Margin Simply Disappears
Compounds are priced from ingredient cost, markup, and a dispensing fee. When any of those is calculated wrong, the reimbursement comes back below what the medication cost you to make - and a prescription you thought was profitable becomes a loss.
Impact: Small pricing errors turn prescriptions you thought were profitable into quiet losses
Specialty Drug Approvals Can Tie Up Your Revenue for Weeks
High-cost specialty medications need extensive approval and detailed clinical justification before a payer will cover them. Every day that approval sits unresolved is a day your money is locked up - or a day the drug sits on your shelf instead of reaching the patient.
Impact: Every day an approval sits unresolved is a day your money is locked up
High-Cost Drugs Get Denied Without the Right Documentation Behind Them
Specialty medications carry strict handling and documentation requirements. When the record doesn't fully support the claim, the payer denies it - and on a drug that can cost thousands of dollars per fill, a single denial is a serious hit to the month's revenue.
Impact: On a drug that costs thousands per fill, a single denial is a serious hit to the month
Items That Straddle Pharmacy and Medical Equipment Get Billed to the Wrong Benefit
Some products your pharmacy dispenses can be covered under either the drug benefit or the medical-equipment benefit. Bill it to the wrong one and the claim is rejected - forcing a rebill, delaying payment, and sometimes losing it altogether when timing deadlines pass.
Impact: Billing an item to the wrong benefit means an automatic rejection and a delayed rebill
Every Payer Plays by Different Rules, and the Difference Is Your Money
Each insurer sets its own requirements for compounds and specialty drugs - what it will cover, what it needs to see, and how it wants the claim filed. Miss one payer's specific rule and an otherwise valid, high-dollar claim comes back denied.
Impact: Miss one payer-specific rule and an otherwise valid, high-dollar claim comes back denied
How We Simplify Pharmacy Reimbursement
Our pharmacy approach focuses on the revenue bottlenecks that matter most: billing accuracy, timely submissions, aggressive denial follow-up, and payer contract optimization.
Compound Claims Billed Ingredient by Ingredient
We bill compound claims ingredient by ingredient, with every quantity and fee captured up front.
- Every ingredient and quantity captured accurately
- Pricing and fees calculated so the reimbursement protects your margin
- Fewer compound denials and costly rebills
- The full cost of the prescription actually recovered
Specialty Medication Billing, Managed End to End
Full management of your high-cost specialty drug claims, with the documentation and payer-specific handling that keeps thousands of dollars per fill from slipping into a denial.
- High-cost drug claims filed and defended correctly
- Manufacturer assistance and copay programs coordinated for patients
- Deep familiarity with how specialty payers actually pay
- Fewer write-offs on your most expensive inventory
Prior Approvals Cleared Before You Dispense
We submit and track approvals for specialty and compound medications before the drug leaves your shelf.
- Approvals tracked until the payer decides
- Clinical documentation assembled to win the approval
- Step-therapy requirements navigated for you
- Appeals pursued when a payer says no
Comprehensive Pharmacy Insurance Billing
Specialty-tuned billing solutions tailored specifically for compounding pharmacies and specialty medication providers.
Compound Drug Billing
Expert billing for compounded medications with proper ingredient billing and cost calculations.
Ingredient billing / Formula tracking / Cost optimization / Compound documentation
Specialty Medications
Specialized billing for high-cost specialty drugs with manufacturer program coordination.
Specialty drug billing / Buy-and-bill services / Copay assistance / Manufacturer rebates
DME-Linked Pharmacy
Expert billing for pharmacy items that qualify under DME benefits with proper classification.
Nebulizer medications / Diabetic supplies / Enteral nutrition / Ostomy supplies
Prior Authorization
Complete PA management for specialty and compound medications with clinical support.
PA submission / Clinical documentation / Step therapy appeals / Formulary management
The Mechanics of Pharmacy Claims
01The 340B Discount Program: Real Savings, But Only If the Rules Are Followed
If your pharmacy serves an eligible safety-net organization - a community health center, a Ryan White clinic, a qualifying hospital - the 340B program lets you buy outpatient drugs at deeply discounted prices, often far below what you're reimbursed for them. That gap is real money for the organization. But the program only works if you can prove those discounted drugs went only to eligible patients and that you never claimed both a 340B discount and a separate government rebate on the same drug.
The record-keeping is where pharmacies get into trouble: dispense a discounted drug to the wrong patient, or double-dip on a rebate, and you're facing repayment demands and audit exposure. Because this program is under heavier scrutiny every year, clean, defensible tracking isn't optional - it's what protects the savings from being clawed back later.
02Specialty Drugs: High Cost, High Denial Risk, and Two Very Different Ways to Get Paid
Specialty medications - biologics, cancer therapies, immune treatments, and the like - are where the largest dollars and the largest risks sit. They're expensive, they often need special storage and patient monitoring, and payers scrutinize them harder than anything else. A crucial money question is who buys and bills the drug: when the drug is administered in a clinical setting, one benefit and one billing path applies; when the patient fills it and takes it themselves, a completely different path applies.
Route the claim down the wrong path and it's denied outright - on a drug that can cost thousands of dollars a fill. Some high-risk drugs also carry mandatory safety-program requirements, and payers frequently insist a lower-cost alternative be tried first unless the record justifies the more expensive choice. Getting each of these right up front is the difference between clean payment and a five-figure write-off.
03Getting Paid for Medication Reviews Your Pharmacists Already Perform
Many pharmacies deliver real clinical value - sitting down with high-risk patients, reviewing every medication they take, catching dangerous interactions, and advising their doctors - without ever billing for it. Medicare's drug program pays for this work through structured medication-review services, but only when the visit is documented and submitted correctly.
A full annual review covers everything the patient takes, including over-the-counter products and supplements, and shorter follow-ups happen between those annual visits. Eligibility usually depends on the patient having several chronic conditions and taking multiple medications. Health systems and care organizations increasingly want this service because it improves outcomes and lowers cost - which means it's both a revenue line and a relationship-builder your pharmacy may be leaving entirely on the table.
Payer Requirements for Pharmacy Denials
Different payers have distinct requirements for Pharmacy Billing billing. Our billers navigate each payer's rules.
- Self-administered drugs the patient takes at home are covered one way; drugs given in a clinical setting are covered another - sending a claim to the wrong side means it's denied
- Medication-review services your pharmacists perform are payable, but only when the visit is properly documented and submitted
- Patients with low-income assistance owe very little out of pocket - confirming their status per drug prevents surprise balances and collection headaches
- Recent law caps what Part D patients pay out of pocket each year, which changes what you can expect to collect directly from them
- If you use the 340B discount program, those drugs have to be kept separate from Medicaid's rebate program - mixing them triggers repayment demands
- Specialty drugs and brand biologics usually require approval and often a lower-cost alternative tried first before Medicaid will pay
- Medicaid generally expects a generic when one exists, so brand claims need justification to avoid denial
- States negotiate extra rebates, so reimbursement here can behave differently than commercial plans - plan cash flow accordingly
- Specialty drugs sit on the highest cost-share tiers, so confirm what the patient owes up front to avoid unpaid balances and abandoned fills
- Many plans force specialty drugs to be filled only through their preferred pharmacies - know when a claim will be redirected before you dispense
- When a patient urgently needs a drug, a step-therapy waiver can be requested, but only with clear clinical justification on the record
- Specialty approvals often expire after a year - tracking renewals keeps a paying patient from lapsing into denials
- Some payers require the drug's NDC on the claim - leaving it off delays or denies payment
- When part of a single-dose vial can't be used, the wasted portion is billable when documented correctly - don't give away drug cost
- Drug reimbursement values change on a set schedule each year; billing on stale figures leaves money on the table
- Manufacturer assistance programs help uninsured and underinsured patients afford biologics - connecting them protects both the patient and your revenue
Frequently Asked Questions About Pharmacy Billing
Expert answers to common questions about pharmacy billing, coding, insurance requirements, and revenue cycle management.
Drug-based billing - pharmacy claims identify the drug by its National Drug Code rather than the procedure codes medical practices use
PBM adjudication - claims are processed at the point of sale through pharmacy benefit managers in the pharmacy claim format set by the National Council for Prescription Drug Programs
Maximum Allowable Cost pricing - PBMs set maximum prices for generics that may fall below acquisition cost
Price concessions - in Medicare Part D
340B program billing - eligible entities purchase drugs at steep discounts but must maintain separate inventory tracking and comply with the duplicate discount prohibition
Specialty pharmacy - high-cost medications with complex prior authorization
Compound prescriptions - billing based on ingredient costs plus a professional fee.
Pharmacy claims adjudication: Point-of-Sale Processing: unlike medical claims, pharmacy claims are adjudicated at the point of sale through a switch to the PBM.
Claim Format: claims use the National Council for Prescription Drug Programs format, not the physician or institutional claim forms.
Key Claim Fields: BIN (bank identification number), PCN (processor control number), group number, member ID, the drug's National Drug Code, quantity dispensed, days supply and the dispense-as-written indicator.
Pricing: PBMs reimburse using formulas based on average wholesale price, maximum allowable cost, or the national average drug acquisition cost.
Copay Tiers: formulary position determines patient copay, from generic (lowest) through preferred brand, non-preferred brand and specialty.
Common Rejections: prior authorization required, plan limits exceeded, refill too soon, and product not covered.
Common pharmacy rejections: Prior Authorization Required: non-formulary or step-therapy drugs need approval - submit through the payer portal with the diagnosis, alternatives tried and clinical rationale.
Refill Too Soon: the patient is refilling before enough of the previous supply has been used - calculate from the last fill date and days supply.
Plan Limitations Exceeded: a quantity limit, age restriction or maximum supply was exceeded - may need a quantity limit exception with clinical documentation.
Product Not Covered: the drug is excluded from the formulary - options include a therapeutic alternative, a formulary exception request or a manufacturer patient assistance program.
Dispense-as-Written Penalty: a brand dispensed when a generic is available without the prescriber's instruction - the patient pays the brand difference or the pharmacy absorbs it.
Fee Clawbacks: in Medicare Part D, price concessions have been applied at the point of sale since 2024, but some commercial PBM contracts still claw back fees after payment.
Still Have Questions?
Our team is ready to answer your specific questions and provide personalized guidance for your practice.
Get More From Pharmacy Reimbursement
Request a free pharmacy revenue analysis. We'll look at your claim acceptance rates, denial patterns, and payer reimbursements to identify where you can improve - and by how much.